Neuromodulation in pediatric drug-resistant epilepsy
Epilepsy & Behavior · 2025
DOI: 10.1016/j.yebeh.2025.110332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Ann Hyslop und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, 750 Welch Rd, Palo Alto, CA 94304, United States. Electron…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Vagus Nerve Stimulation, Deep Brain Stimulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
This is a summary of the three commercially available neuromodulation devices for refractory epilepsy, highlighting their use in children. The article offers a high-level review of the proposed mechanisms of vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation, the pivotal trials leading to their approval for use in the United States, as well as their efficacy and associated adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, 750 Welch Rd, Palo Alto, CA 94304, United States. Electronic address: hyslop@stanford.edu.
- Department of Neurology, Nicklaus Children's Health System, 3100 SW 62nd Ave, Miami, FL 33155, United States. Electronic address: Marytery.Fajardo@Nicklaushealth.org.
Zitieren
APA
Hyslop, A., & Fajardo, M. (2025). Neuromodulation in pediatric drug-resistant epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110332
Vancouver
Hyslop A, Fajardo M. Neuromodulation in pediatric drug-resistant epilepsy. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110332
BibTeX
@article{Hyslop2025,
author = {Hyslop, Ann and Fajardo, Marytery},
title = {Neuromodulation in pediatric drug-resistant epilepsy},
journal = {Epilepsy & Behavior},
year = {2025},
doi = {10.1016/j.yebeh.2025.110332}
}
EUVIMED